Sirona Biochem Corp Total Assets
Sirona Biochem Corp total assets. Based on the latest financial reports, Sirona Biochem Corp (SBM) holds total assets worth CA$809.18K CAD (≈ $585.35K USD) as of July 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see SBM stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Sirona Biochem Corp (2011–2023)
Total assets of Sirona Biochem Corp from 2011 to 2023. This chart illustrates how Sirona Biochem Corp's total assets have evolved over time, based on quarterly financial data. See today's stock price for Sirona Biochem Corp for real-time trading data and today's change.
Sirona Biochem Corp - Asset Composition Analysis
Sirona Biochem Corp Total Assets Breakdown (October 2023)
Sirona Biochem Corp total assets breakdown as of October 2023. Sirona Biochem Corp's total assets of CA$809.18K consist of 99.1% current assets and 0.9% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 55.4% |
| Accounts Receivable | CA$6.61K | 0.6% |
| Inventory | CA$0.00 | 0.0% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$0.00 | 0.0% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2011–2023)
This chart illustrates how Sirona Biochem Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Sirona Biochem Corp to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sirona Biochem Corp's current assets represent 99.1% of total assets in 2023, an increase from 37.9% in 2011.
- Cash Position: Cash and equivalents constituted 55.4% of total assets in 2023, up from 6.6% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 59.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 0.6% of total assets.
Sirona Biochem Corp Competitors by Total Assets
Key competitors of Sirona Biochem Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
CSL Ltd
AU:CSL
|
Australia | AU$39.54 Billion |
|
Genmab A/S
CO:GMAB
|
Denmark | Dkr7.02 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Xizang Haisco Pharmaceutical Group Co Ltd
SHE:002653
|
China | CN¥7.88 Billion |
|
Abivax SA American Depositary Shares
NASDAQ:ABVX
|
USA | $462.21 Million |
|
Bachem Holding AG
SW:BANB
|
Switzerland | CHF2.11 Billion |
|
Viking Therapeutics Inc
NASDAQ:VKTX
|
USA | $521.90 Million |
|
SOLENO THERAPEUT. DL-001
F:6XC
|
Germany | €563.83 Million |
Sirona Biochem Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.34 | 1.50 | 4.63 |
| Quick Ratio | 0.34 | 1.50 | 4.63 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$-1.57 Million | CA$361.97K | CA$3.34 Million |
Sirona Biochem Corp - Advanced Valuation Insights
This section examines the relationship between Sirona Biochem Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 41.64 |
| Latest Market Cap to Assets Ratio | 10.89 |
| Asset Growth Rate (YoY) | -20.0% |
| Total Assets | CA$1.03 Million |
| Market Capitalization | $11.23 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Sirona Biochem Corp's assets at a significant premium (10.89x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Sirona Biochem Corp's assets decreased by 20.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Sirona Biochem Corp (2011–2023)
The table below shows the annual total assets of Sirona Biochem Corp from 2011 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-10-31 | CA$1.03 Million ≈ $746.59K |
-20.04% |
| 2022-10-31 | CA$1.29 Million ≈ $933.68K |
+0.25% |
| 2021-10-31 | CA$1.29 Million ≈ $931.33K |
-39.76% |
| 2020-10-31 | CA$2.14 Million ≈ $1.55 Million |
-49.79% |
| 2019-10-31 | CA$4.26 Million ≈ $3.08 Million |
+452.48% |
| 2018-10-31 | CA$770.51K ≈ $557.38K |
-38.41% |
| 2017-10-31 | CA$1.25 Million ≈ $904.98K |
-59.97% |
| 2016-10-31 | CA$3.13 Million ≈ $2.26 Million |
-24.65% |
| 2015-10-31 | CA$4.15 Million ≈ $3.00 Million |
+20.99% |
| 2014-10-31 | CA$3.43 Million ≈ $2.48 Million |
+2.51% |
| 2013-10-31 | CA$3.34 Million ≈ $2.42 Million |
+24.88% |
| 2012-10-31 | CA$2.68 Million ≈ $1.94 Million |
-22.51% |
| 2011-10-31 | CA$3.46 Million ≈ $2.50 Million |
-- |
About Sirona Biochem Corp
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company … Read more